Skip to main content

Articles

Page 5 of 40

  1. The risk for and treatment of cardiovascular disease (CVD) in type 2 diabetes (T2DM) is often incorrect and delayed. We wished to determine if a novel test improved physicians’ ability to risk stratify, diagno...

    Authors: John W. Peabody, David Paculdo, Enrico de Belen, Divya Ganesan, Isabella Cooney and Nelson Trujillo
    Citation: Diabetology & Metabolic Syndrome 2023 15:155
  2. Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are commonly used in the management of type 2 diabetes mellitus (T2DM) and have been found to worsen the reduction of skeletal muscle mass in individuals with...

    Authors: Xudong Yang, Lifeng Wang, Liangzhi Zhang, Xia Zhai, Xiusheng Sheng, Helong Quan and Hengjun Lin
    Citation: Diabetology & Metabolic Syndrome 2023 15:154

    The Correction to this article has been published in Diabetology & Metabolic Syndrome 2023 15:171

  3. Authors: Morteza Izadi, Mohammad Javanbakht, Ali Sarafzadeh, Behzad Einollahi, Farzaneh Futuhi, Zahra Vahedi, Shi Zhao, Nematollah Jonaidi‑Jafari, Mahboobeh Sadat Hosseini, Javad Hosseini Nejad, Effat Naeimi, Seyed Hassan Saadat, Hadi Esmaeili Gouvarchin Ghaleh, Mozhgan Fazel, Zahra Einollahi and Luca Cegolon
    Citation: Diabetology & Metabolic Syndrome 2023 15:153

    The original article was published in Diabetology & Metabolic Syndrome 2023 15:140

  4. Recent studies have shown that the addition of sodium-glucose co-transporter 2 (SGLT2) inhibitors gradually reduces the estimated fluid volume parameters in a broad range of patient populations, suggesting tha...

    Authors: Atsushi Tanaka, Takumi Imai, Shigeru Toyoda, Kazuhiro Sugimoto, Ruka Yoshida, Machi Furuta and Koichi Node
    Citation: Diabetology & Metabolic Syndrome 2023 15:152
  5. Type 2 diabetes (T2DM) patients, including those in good glycemic control, have an increased risk of cardiovascular disease (CVD). Maintaining good glycemic control with drugs may reduce long-term CVD risk. Br...

    Authors: Mulualem Tesfaye Birhan, Teklie Mengie Ayele, Fikire Wondimu Abebe and Fiseha Nigussie Dgnew
    Citation: Diabetology & Metabolic Syndrome 2023 15:151
  6. Type 2 diabetes mellitus is one of the most common causes of chronic kidney disease (CKD) worldwide and prevalence of 1.75 per 100 inhabitants in Colombia. The aim of this study was to describe the treatment p...

    Authors: Manuel E Machado-Duque, Andres Gaviria-Mendoza, Luis F Valladales-Restrepo, Juan Sebastian Franco, Maria de Rosario Forero, David Vizcaya and Jorge E Machado-Alba
    Citation: Diabetology & Metabolic Syndrome 2023 15:150
  7. Exosomes from adipose-derived stem cells (ADSCs-Exos) have exhibited a therapeutic role in diabetic nephropathy (DN). Further studies are needed to investigate how ADSCs-Exos regulate oxidative stress and infl...

    Authors: Peiyao Ren, Fengmei Qian, Lanjun Fu, Wenfang He, Qiang He, Juan Jin and Danna Zheng
    Citation: Diabetology & Metabolic Syndrome 2023 15:149
  8. Diabetic peripheral neuropathy (DPN) is a common complication of diabetes mellitus (DM) that can cause annoying symptoms. To address this condition, several treatment approaches have been proposed, including s...

    Authors: Armin Nazeri, Ali Mohammadpour, Mohammad-Hadi Saeed Modaghegh and Mojtaba Kianmehr
    Citation: Diabetology & Metabolic Syndrome 2023 15:148
  9. This meta-analysis was conducted given the contradictory findings from studies on the influence of diabetes duration or age at onset on mortality in patients with insulin-dependent diabetes mellitus (IDDM).

    Authors: Xing-mu Wang, Shu-ping Zhong, Gang-feng Li and Fu-yuan Zhuge
    Citation: Diabetology & Metabolic Syndrome 2023 15:147
  10. Metabolomic signatures of type 2 diabetes mellitus (T2DM) in Tibetan Chinese population, a group with high diabetes burden, remain largely unclear. Identifying the serum metabolite profile of Tibetan T2DM (T-T...

    Authors: Jinli Meng, Fangfang Huang, Jing Shi, Chenghui Zhang, Li Feng, Suyuan Wang, Hengyan Li, Yongyue Guo, Xin Hu, Xiaomei Li, Wanlin He, Jian Cheng and Yunhong Wu
    Citation: Diabetology & Metabolic Syndrome 2023 15:146
  11. Prediabetes is a transitional state between normal blood glucose levels and diabetes, but it is also a reversible process. At the same time, as one of the most important tissues in the human body, the metaboli...

    Authors: Yu Tian, Dongxu Shi, Haiying Liao, Binan Lu and Zongran Pang
    Citation: Diabetology & Metabolic Syndrome 2023 15:145
  12. Type 1 diabetes mellitus (T1D) is a condition resulting from autoimmune destruction of pancreatic β cells, leading patients to require lifelong insulin therapy, which, most often, does not avoid the most common c...

    Authors: Marluce da Cunha Mantovani, Ilana Gabanyi, Carlos Andrés Pantanali, Vinícius Rocha Santos, Maria Lúcia Cardillo Corrêa-Giannella and Mari Cleide Sogayar
    Citation: Diabetology & Metabolic Syndrome 2023 15:144
  13. This study aimed to investigate the relationship between the TyG (Triglyceride-glucose index) and the prognosis of patients with HOCM (hypertrophic obstructive cardiomyopathy) without diabetes.

    Authors: Xiangbin Meng, Jun Gao, Kuo Zhang, Wen Jun, Jing-Jia Wang, Xu-Liang Wang, Yuan-Geng-Shuo Wang, Ji-Lin Zheng, Yu-Peng Liu, Jing-Jing Song, Jie Yang, Yi-Tian Zheng, Chen Li, Wen-Yao Wang, Chunli Shao and Yi-Da Tang
    Citation: Diabetology & Metabolic Syndrome 2023 15:143
  14. Acute myocardial infarction (AMI) is the most prevalent cause of mortality and morbidity in patients with type 2 diabetes mellitus (T2DM). However, strict blood glucose control does not always prevent the deve...

    Authors: Ning Cao, Yichun Wang, Boyi Bao, Man Wang, Jiayu Li, Wenxi Dang, Bing Hua, Lijin Song, Hongwei Li and Weiping Li
    Citation: Diabetology & Metabolic Syndrome 2023 15:142
  15. Heart failure with preserved ejection fraction (HFpEF) is a common disease with high morbidity and lacks effective treatment. We investigated the protective effects of the long-term application of the sodium-g...

    Authors: Bin Feng, Peiran Yu, Hao Yu, Buyun Qian, Yuan Li, Kangyun Sun, Bimin Shi, Nannan Zhang and Guidong Xu
    Citation: Diabetology & Metabolic Syndrome 2023 15:141
  16. The involvement of the central nervous system is a frequent yet underestimated complication of diabetes mellitus. Visual evoked potentials (VEP) are a simple, sensitive, and noninvasive method for detecting ea...

    Authors: Morteza Izadi, Mohammad Javanbakht, Ali Sarafzadeh, Behzad Einollahi, Farzaneh Futuhi, Zahra Vahedi, Shi Zhao, Nematollah Jonaidi-Jafari, Mahboobeh Sadat Hosseini, Javad Hosseini Nejad, Effat Naeimi, Seyed Hassan Saadat, Hadi Esmaeili Gouvarchin Ghaleh, Mozhgan Fazel, Zahra Einollahi and Luca Cegolon
    Citation: Diabetology & Metabolic Syndrome 2023 15:140

    The Correction to this article has been published in Diabetology & Metabolic Syndrome 2023 15:153

  17. Despite the wide acceptability of fasting lipid profiles in practice, emerging evidence suggests that random lipid profiles might be a convenient alternative for lipid measurement. The objective of the present...

    Authors: A. B. M. Kamrul-Hasan, Samir Kumar Talukder, Md Ahamedul Kabir, Marufa Mustari, Md Masud Un Nabi, Abu Jar Gaffar, Md Firoj Hossain, Muhammad Shah Alam, Md Rashedul Islam, Mohammad Abdul Hannan, Nusrat Zarin, Ajit Kumar Paul, Farhana Akter, Afsar Ahammed, Md Lutful Kabir, Mohammad Motiur Rahman…
    Citation: Diabetology & Metabolic Syndrome 2023 15:139
  18. Percutaneous coronary intervention (PCI) is one of the most performed well-succeeded therapeutic procedures worldwide, reducing symptoms and improving quality of life. Neutrophil Gelatinase-associated Lipocali...

    Authors: Mateus Paiva Marques Feitosa, Eduardo Gomes Lima, Alexandre Antônio Cunha Abizaid, Roxana Mehran, Neuza Helena Moreira Lopes, Thiago de Assis Fischer Ramos, Alexandre Hideo-Kajita, Roberto Kalil Filho and Carlos Vicente Serrano Junior
    Citation: Diabetology & Metabolic Syndrome 2023 15:138
  19. Recently, metabolic dysfunction-associated fatty liver disease (MAFLD) has been proposed to replace non-alcoholic fatty liver disease (NAFLD) to emphasize the pathogenic association between fatty liver disease...

    Authors: Zhihao Wei, Zhe Huang, Zongshuang Song, Wenliu Zhao, Dandan Zhao, Yizhen Tan, Shuohua Chen, Peng Yang, Yun Li and Shouling Wu
    Citation: Diabetology & Metabolic Syndrome 2023 15:137
  20. The evidence on the association between the triglyceride glucose (TyG) index and the risk of death in the general population remains controversial. This study aims to investigate the relationship between the T...

    Authors: Yu Yu, Jing Wang, Ligang Ding, Hao Huang, Sijing Cheng, Yu Deng, Min Gu, Chi Cai, Xiaohui Ning, Xuhua Chen, Hongxia Niu and Wei Hua
    Citation: Diabetology & Metabolic Syndrome 2023 15:136
  21. Many previous studies have reported the association between iron overload (IO) and type 2 diabetes mellitus (T2DM). However, the underlying molecular mechanism is not clear.

    Authors: Xuekui Liu, Xiu Hong, Shiqiang Jiang, Rui Li, Qian Lv, Jie Wang, Xiuli Wang, Manqing Yang, Houfa Geng and Yang Li
    Citation: Diabetology & Metabolic Syndrome 2023 15:134
  22. Despite that several original researchers have investigated the association between neck circumference (NC) and the risk of diabetes mellitus (DM), their results remain controversial. This review aimed to quan...

    Authors: Dandan Li, Yuxin Zhao, Lifang Zhang, Qiqi You, Qingqing Jiang, Xiaoxv Yin and Shiyi Cao
    Citation: Diabetology & Metabolic Syndrome 2023 15:133
  23. To assess the association of pregnancy loss history with an elevated risk of Gestational diabetes mellitus (GDM) and to investigate whether this association was mediated by high-sensitivity C-reactive protein ...

    Authors: Qiong Li, Haixia Wang, Lijun Sun, Peng Wang, Wanjun Yin, Shuangshuang Ma, Ruixue Tao, Jinfang Ge and Peng Zhu
    Citation: Diabetology & Metabolic Syndrome 2023 15:132
  24. To investigate the associations of composite dietary antioxidant index (CDAI) with risk of cardiovascular disease (CVD) mortality among individuals with type 2 diabetes (T2D). This prospective cohort study inc...

    Authors: Chan Yang, Qiangfei Yang, Xi Peng, Xinqiong Li and Guocheng Rao
    Citation: Diabetology & Metabolic Syndrome 2023 15:131
  25. Acylcarnitines play a role in type 2 diabetes mellitus (T2DM), but the relationship between acylcarnitine and diabetic nephropathy was unclear. We aimed to explore the association of acylcarnitine metabolites ...

    Authors: Xuerui Li, Yuyang Miao, Zhongze Fang and Qiang Zhang
    Citation: Diabetology & Metabolic Syndrome 2023 15:130
  26. Metabolic syndrome (MetS), a clustering of traditional cardiovascular risk factors (CVRF), is currently one of the major global public health burdens. However, associations between MetS and non-traditional CVR...

    Authors: Aijun You, Yaxin Li, Chaonan Shen, Huimin Fan, Jia He, Zhongmin Liu, Qian Xue, Yuzhen Zhang and Liang Zheng
    Citation: Diabetology & Metabolic Syndrome 2023 15:129
  27. Prognostic models in patients living with diabetes allow physicians to estimate individual risk based on medical records and biological results. Clinical risk factors are not always all available to evaluate t...

    Authors: Alexandre Vimont, Sophie Béliard, René Valéro, Henri Leleu and Isabelle Durand-Zaleski
    Citation: Diabetology & Metabolic Syndrome 2023 15:128
  28. Several meta-analyses reported glycemic-lowering effects of cinnamon, while others reported conflicting findings. In the present study, we aimed to perform an umbrella meta-analysis of previous interventional ...

    Authors: Meysam Zarezadeh, Vali Musazadeh, Elaheh Foroumandi, Majid Keramati, Alireza Ostadrahimi and Rania A. Mekary
    Citation: Diabetology & Metabolic Syndrome 2023 15:127
  29. The potential effects of time factor and albuminuria on the morbid alterations in patients with type 2 diabetes (T2D) and COVID-19 are still unclear. We aimed to address the morbid alterations and the potentia...

    Authors: Mohammed Ali Gameil, Rehab Elsayed Marzouk, Ahmed Hassan El-Sebaie and Ahmed Ahmed Ahmed Eldeeb
    Citation: Diabetology & Metabolic Syndrome 2023 15:126
  30. Abnormal lipid metabolism is associated with gestational diabetes mellitus (GDM) in singleton pregnancies. Data were lacking on twin pregnancies with GDM. We explored the association between serum lipid profil...

    Authors: Kexin Zhang, Wei Zheng, Xianxian Yuan, Jia Wang, Ruihua Yang, Yuru Ma, Weiling Han, Junhua Huang, Kaiwen Ma, Puyang Zhang, Lili Xu, Lirui Zhang, Xin Yan, Tengda Chen, Yujie Zhang and Guanghui Li
    Citation: Diabetology & Metabolic Syndrome 2023 15:125
  31. Obesity is a chronic disease resulting from multifactorial causes mainly related to lifestyle (sedentary lifestyle, inadequate eating habits) and to other conditions such as genetic, hereditary, psychological,...

    Authors: Renata Bressan Pepe, Ana Maria Lottenberg, Clarissa Tamie Hiwatashi Fujiwara, Mônica Beyruti, Dennys Esper Cintra, Roberta Marcondes Machado, Alessandra Rodrigues, Natália Sanchez Oliveira Jensen, Ana Paula Silva Caldas, Ariana Ester Fernandes, Carina Rossoni, Fernanda Mattos, João Henrique Fabiano Motarelli, Josefina Bressan, Juliana Saldanha, Lis Mie Masuzawa Beda…
    Citation: Diabetology & Metabolic Syndrome 2023 15:124
  32. Recent evidence suggests increased glucose variability (GV) causes endothelial dysfunction, a central pathology of hypertensive disorders of pregnancy (HDP). We aimed to investigate the association between GV ...

    Authors: Sho Tano, Tomomi Kotani, Takafumi Ushida, Masato Yoshihara, Kenji Imai, Noriyuki Nakamura, Yukako Iitani, Yoshinori Moriyama, Ryo Emoto, Sawako Kato, Shigeru Yoshida, Mamoru Yamashita, Yasuyuki Kishigami, Hidenori Oguchi, Shigeyuki Matsui and Hiroaki Kajiyama
    Citation: Diabetology & Metabolic Syndrome 2023 15:123
  33. The contribution of chronic kidney disease (CKD) to mortality in diabetic patients is unclear. This study aimed to explore the association between diabetics with CKD and mortality in middle-aged and elderly pe...

    Authors: Xihong Liao, Ke Shi, Yumeng Zhang, Xiaoxu Huang, Ning Wang, Ling Zhang and Xiaohuan Zhao
    Citation: Diabetology & Metabolic Syndrome 2023 15:122
  34. Observational studies have reported an inverse association of type 2 diabetes (T2D) with thoracic aortic aneurysm (TAA). However, the causality of the association has not been established yet. The present stud...

    Authors: Yiran Zhang, Yongxin Li, Xiaoyi Dai, Haokai Lin and Liang Ma
    Citation: Diabetology & Metabolic Syndrome 2023 15:120
  35. Long noncoding RNAs (LncRNAs) have been identified to play an important role in diabetes. The aim of the present study was to determine the expression and function of small nucleolar RNA host gene 16 (SNHG16) ...

    Authors: Linjuan Huang, Shengxi Xiong, Hanshuang Liu, Ranran Zhang, Ying Wu and Xiaolei Hu
    Citation: Diabetology & Metabolic Syndrome 2023 15:119
  36. Gestational diabetes mellitus (GDM) represents the main metabolic alteration during pregnancy. The available methods for diagnosing GDM identify women when the disease is established, and pancreatic beta-cell ...

    Authors: Melissa Razo-Azamar, Rafael Nambo-Venegas, Noemí Meraz-Cruz, Martha Guevara-Cruz, Isabel Ibarra-González, Marcela Vela-Amieva, Jaime Delgadillo-Velázquez, Xanic Caraza Santiago, Rafael Figueroa Escobar, Felipe Vadillo-Ortega and Berenice Palacios-González
    Citation: Diabetology & Metabolic Syndrome 2023 15:116
  37. Diabetes is a metabolic disorder of glucose homeostasis in which β cell destruction occurs silently and is detected mainly when symptoms appear. In the last few years, it has emerged a great interest in develo...

    Authors: Teresa María Linares-Pineda, Carolina Gutiérrez-Repiso, Nerea Peña-Montero, María Molina-Vega, Fuensanta Lima Rubio, María Suárez Arana, Francisco J. Tinahones, María José Picón-César and Sonsoles Morcillo
    Citation: Diabetology & Metabolic Syndrome 2023 15:115
  38. Pathophysiological mechanisms underlying sex-based differences in diabetes remain poorly understood. Mitochondrial metabolite methylmalonic acid (MMA) accumulation reflects mitochondrial dysfunction which is i...

    Authors: Shanjie Wang, JunChen Guo, Xiaoxuan Liu, Wei Tian, Yiying Zhang, Ye Wang, Yige Liu, Mingyan E. and Shaohong Fang
    Citation: Diabetology & Metabolic Syndrome 2023 15:114
  39. Sodium-glucose cotransporter-2 (SGLT-2) inhibitors therapies were reported to affect adipose tissue distribution. However, the available evidence about the effect of SGLT-2 inhibitor on adipose tissue is contr...

    Authors: Xianghong Wang, Niujian Wu, Chuanchuan Sun, Donghua Jin and Hongyun Lu
    Citation: Diabetology & Metabolic Syndrome 2023 15:113
  40. The Triglyceride and Glucose (TyG) index has been found to have a strong correlation with the recurrence of acute ischemic stroke (AIS) and poor patient outcomes. Nevertheless, the relationship between the TyG...

    Authors: Jia Wang, Hao Tang, Xiaokun Wang, Jiarong Wu, Jiaqi Gao, Shuang Diao and Yun Wu
    Citation: Diabetology & Metabolic Syndrome 2023 15:112
  41. The purpose of the study was to compare the efficacy of two novel obesity indices, lipid accumulation product (LAP) and visceral adiposity index (VAI), with traditional obesity indices in predicting early-onse...

    Authors: Chen-Ying Lin, Jing-Bo Li, Fan Wu, Jun-Jia Wang, Hao-Hua An, Hui-Na Qiu, Long-Fei Xia, Yao-Shuang Li, Ya-Jie Zhai, Chun-Jun Li and Jing-Na Lin
    Citation: Diabetology & Metabolic Syndrome 2023 15:111
  42. Clinical comparisons of angiotensin receptor–neprilysin inhibitors (ARNI) and sodium–glucose cotransporter 2 inhibitors (SGLT2i) treatment in patients with HFrEF and T2DM are limited. This study evaluated the ...

    Authors: Ming-Lung Tsai, Yuan Lin, Ming-Shyan Lin, Tzu-Hsien Tsai, Ning-I Yang, Chao-Yung Wang, I-Chang Hsieh, Ming-Jui Hung and Tien-Hsing Chen
    Citation: Diabetology & Metabolic Syndrome 2023 15:110
  43. In the general population, metabolic syndrome (MetS) is associated with increased risk of cognitive impairment, including global and specific cognitive domains. These associations are not well studied in patie...

    Authors: Yuqi Yang, Qian Li, Yanjun Long, Jing Yuan and Yan Zha
    Citation: Diabetology & Metabolic Syndrome 2023 15:108
  44. A Mediterranean-style diet (MED) can promote people lengthen the span of life and avoid atherosclerotic cardiovascular disease (ASCVD) in primary prevention. Metabolic syndrome (MetS) can significantly reduce ...

    Authors: Hongxuan Fan, Yongle Wang, Zhaoyu Ren, Xuchang Liu, Jianqi Zhao, Yalin Yuan, Xiaoning Fei, Xiaosu Song, Fengqin Wang and Bin Liang
    Citation: Diabetology & Metabolic Syndrome 2023 15:107

New Content Item

The official journal of the Brazilian Diabetes Society.

Annual Journal Metrics

  • 2022 Citation Impact
    4.8 - 2-year Impact Factor
    4.7 - 5-year Impact Factor
    1.476 - SNIP (Source Normalized Impact per Paper)
    1.195 - SJR (SCImago Journal Rank)

    2023 Speed
    4 days submission to first editorial decision for all manuscripts (Median)
    87 days submission to accept (Median)

    2023 Usage 
    1,322,026 downloads
    1,058 Altmetric mentions